An Open Randomised Controlled Trial for Optimzing Antivenom Therapy Among Carpet Viper Envenomed Children in Northeastern Nigeria

Phase 4

Not yet recruiting

• Conditions: Injury, Occupational Diseases, Poisoning

• Registration Number: PACTR202106915491232
• Lead Sponsor: Venom Antivenom Research Project Bayero University Kano

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-06-11
• Last Update Posted: 2023-05-29

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

1-Children aged 12 months to 12 years
2-Availability of intravenous access
3-Mild to moderately envenomed patients
4-Presentation within 72 hours of bite

Exclusion Criteria

1-Severely envenomed sick children that are or have:
a.Collapsed or in unresponsive shock
b.Grade III of the snakebite severity score
c.Severe anaemia with packed cell volume (PCV) less than 12%
d.Non-transient unconscious patients
e.Patients with severe delayed gangrenous body part
f.Suspicion of acute end-organ complications e.g., acute kidney injury (AKI)
g.Other
2-Inability to obtain intravenous access for antivenom administration or blood collection
3-Children less than 12 months
4-Other severe co-morbidities

Study & Design

• Study Type: Interventional
• Study Design: Not specified